Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer

American Journal of Roentgenology

Volumn 186, Issue 3, 2006, Pages 743-748

  Wang, Liang ^a   Hricak, Hedvig ^a   Kattan, Michael W ^a,b   Schwartz, Lawrence H ^a   Eberhardt, Steven C ^a,c   Chen, Hui Ni ^a   Scardino, Peter T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Biopsy; Genitourinary tract imaging; MRI; Oncologic imaging; Prostate; Prostate cancer

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER INVASION; CANCER STAGING; DIAGNOSTIC ACCURACY; ENDORECTAL MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PHASED ARRAY MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE; STATISTICAL SIGNIFICANCE; BIOPSY; BLOOD; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PELVIS; PREDICTION AND FORECASTING; PROSTATE TUMOR; PROSTATECTOMY; ROC CURVE;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; BIOPSY; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 33645800184     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.04.1682     Document Type: Article

References (36)

1. American Cancer Society. Cancer facts & figures 2005. Atlanta, GA: American Cancer Society, 2005. Report no. 5008.05
2. Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003; 170:1798-1803
3. Partin AW, Pound CR, Clemens JQ, Epstein JI, Walsh PC. Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 1993; 20:713-725
4. Gervasi LA, Mata J, Easley JD, et al. Prognostic significance of lymph nodal metastases in prostate cancer. J Urol 1989; 142(2 Pt 1):332-336
5. Hricak H, Schoder H, Pucar D, et al. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. Semin Oncol 2003; 30:616-634
6. Bezzi M, Kressel HY, Allen KS, et al. Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 1988; 169:339-346
7. Beer M, Schmidt H, Riedl R. The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography [in German]. Urologe A 1989; 28:65-69
8. Kier R, Wain S, Troiano R. Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. AJR 1993; 161:601-606
9. Nicolas V, Beese M, Keulers A, Bressel M, Kastendieck H, Huland H. MR tomography in prostatic carcinoma: comparison of conventional and endorectal MRT [in German]. Rofo 1994; 161:319-326
10. Jager GJ, Barentsz JO, Oosterhof GO, Wirjes JA, Ruijs SJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR 1996; 167:1503-1507
11. Perrotti M, Kaufman RP Jr, Jennings TA, et al. Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 1996; 156:106-109
12. Tuzel E, Sevinc M, Obuz F, Sade M, Kirkali Z. Is magnetic resonance imaging necessary in the staging of prostate cancer? Urol Int 1998; 61:227-231
13. Borley N, Fabrin K, Sriprasad S, et al. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT. Scand J Urol Nephrol 2003; 37:382-386
14. Harisinghani MG, Barentsz J, Hahn PF, et al. Non-invasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348:2491-2499
15. Hricak H, Dooms GC, Jeffrey RB, et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology 1987; 162:331-336
16. Wolf JS Jr, Cher M, Dall'era M, Presti JC Jr, Hricak H, Carroll PR. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995; 153(3 Pt 2):993-999
17. Tempany C, McNeil BJ. Advances in biomedical imaging. JAMA 2001; 285:562-567
18. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994; 44:7-26
19. Soh S, Kattan MW, Berkman S, Wheeler TM, Scardino PT. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 1997; 157:2212-2218
20. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277:1445-1451
21. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 2001; 58:843-848
22. Blute ML, Bergstralh FJ, Partin AW, et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000; 164:1591-1595
23. Augustin H, Eggert T, Wenske S, et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 2004; 171:177-181
24. Graefen M, Augustin H, Karakiewicz PI, et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003; 43:6-11
25. Graefen M, Karakiewicz PI, Cagiannos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 2002; 20:951-956
26. Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect the neurovascular bundles during radical retropubic prostatectomy. Cancer 2004; 100:2655-2663
27. Wang L, Mullerad M, Chen HN, et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. Radiology 2004; 232:133-139
28. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 2004; 232:140-146
29. Yossepowitch O, Sircar K, Scardino PT, et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. J Urol 2002; 168:2011-2015
30. Kattan MW. Judging new markers by their ability to improve predictive accuracy. J Natl Cancer Inst 2003; 95:634-635
31. Fleming ID, Cooper JS, Henson DE, et al. (American Joint Committee on Cancer), eds. Cancer staging manual, 5th ed. Philadelphia, PA: Lippincott-Raven, 1997
32. Parker CC, Dearnaley DP. Radical radiotherapy for prostate cancer. Cancer Treat Rev 2003; 29:161-169
33. Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostate-ctomy. J Clin Oncol 2002; 20:3206-3212
34. Vargas SO, Jiroutek M, Welch WR, Nucci MR, D'Amico AV, Renshaw AA. Perineural invasion in prostate needle biopsy specimens: correlation with extraprostatic extension at resection. Am J Clin Pathol 1999; 111:223-228
35. Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003; 169:1653-1661
36. Cheng L, Bergstralh EJ, Cheville JC, et al. Cancer volume of lymph node metastasis predicts progression in prostate cancer. Am J Surg Pathol 1998; 22:1491-1500